Family-Based Prevention Program for Childhood Anxiety
Study Details
Study Description
Brief Summary
This study will evaluate the effectiveness of a short-term family-based program for preventing anxiety disorders in at-risk children.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Anxiety disorders are serious conditions that can negatively impact a person's overall functioning. This study will enroll mothers with anxiety disorders and their children to determine whether a brief family-based intervention will reduce childhood anxiety better than standard care.
Participants will be randomly assigned to either the family-based prevention program or to evaluation only for 8 weeks. Participants in the prevention program will have weekly sessions with a therapist and will learn skills to help reduce anxiety. Self- and parent-reports, diagnostic interviews, a computerized memory task, and a videotaped parent-child interaction task will be used to assess participants. Assessments will be conducted at study start and one week after intervention completion (Week 9). Follow-up visits will be conducted at 6 and 12 months after intervention completion.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Family-based anxiety prevention program Participants will complete an 8 session (1 session/week), cognitive behavioral therapy-based, family prevention program to be administered by a trained clinician, after randomization to the study. The prevention program will include 3 booster sessions that take place after the first 8 sessions. |
Behavioral: Family-Based Anxiety Prevention Program
Participants in the prevention program will have weekly sessions with a therapist and will learn skills to help reduce anxiety for 8 weeks. The intervention will begin immediately after randomization to the study.
|
Active Comparator: Evaluation only Waitlist control group. Participants in this group will receive general information (in the form of a printed packet) about anxiety after randomization to the study. Families in this group will complete all study evaluations and will then be offered the option of participating in the prevention program. Families who accept will begin the prevention sessions and will receive the same CBT-based, family-based prevention program as the other treatment arm. |
Behavioral: Evaluation only
Participants will undergo evaluations without active treatment for 8 weeks.
|
Outcome Measures
Primary Outcome Measures
- Number of Children With Child Anxiety Diagnosis [12 month]
Measured by the Anxiety Disorder Interview Schedule for the Diagnostic and Statistical Manual of Mental Disorders 4th edition, child and parent versions.
- Child Anxiety Diagnoses [12 months]
The cumulative number of children who developed an anxiety disorder at each assessment point during the study. Using the intent to treat sample, a total of 6 children in the non-intervention group developed an anxiety disorder by the 12-month assessment. No children in the CAPS group developed an anxiety disorder.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Mothers with a current, primary anxiety disorder
-
7-12 year old children without an anxiety disorder
Exclusion Criteria:
-
Mothers that do not have a current, primary anxiety disorder
-
7-12 year old children with an anxiety disorder
-
7-12 year old children that are currently receiving treatment for anxiety that could interfere with the study
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Johns Hopkins University School of Medicine | Baltimore | Maryland | United States | 21205 |
Sponsors and Collaborators
- Johns Hopkins University
- National Institute of Mental Health (NIMH)
Investigators
- Principal Investigator: Golda S. Ginsburg, PhD, Johns Hopkins University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- K23MH063427
- K23MH063427
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | 1 Family-based Prevention Program | 2 Evaluation Only |
---|---|---|
Arm/Group Description | Family-Based Anxiety Prevention Program : Participants in the prevention program will have weekly sessions with a therapist and will learn skills to help reduce anxiety for 8 weeks. | Evaluation only : Participants will undergo evaluations without active treatment for 8 weeks. |
Period Title: Overall Study | ||
STARTED | 20 | 20 |
COMPLETED | 16 | 17 |
NOT COMPLETED | 4 | 3 |
Baseline Characteristics
Arm/Group Title | 1 Family-based Prevention Program | 2 Evaluation Only | Total |
---|---|---|---|
Arm/Group Description | Family-Based Anxiety Prevention Program : Participants in the prevention program will have weekly sessions with a therapist and will learn skills to help reduce anxiety for 8 weeks. | Evaluation only : Participants will undergo evaluations without active treatment for 8 weeks. | Total of all reporting groups |
Overall Participants | 20 | 20 | 40 |
Age (Count of Participants) | |||
<=18 years |
20
100%
|
20
100%
|
40
100%
|
Between 18 and 65 years |
0
0%
|
0
0%
|
0
0%
|
>=65 years |
0
0%
|
0
0%
|
0
0%
|
Age (years) [Mean (Standard Deviation) ] | |||
Mean (Standard Deviation) [years] |
9.20
(1.91)
|
8.68
(1.81)
|
8.94
(1.85)
|
Sex: Female, Male (Count of Participants) | |||
Female |
10
50%
|
8
40%
|
18
45%
|
Male |
10
50%
|
12
60%
|
22
55%
|
Region of Enrollment (participants) [Number] | |||
United States |
20
100%
|
20
100%
|
40
100%
|
Outcome Measures
Title | Number of Children With Child Anxiety Diagnosis |
---|---|
Description | Measured by the Anxiety Disorder Interview Schedule for the Diagnostic and Statistical Manual of Mental Disorders 4th edition, child and parent versions. |
Time Frame | 12 month |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | 1 Family-based Prevention Program | 2 Evaluation Only |
---|---|---|
Arm/Group Description | Family-Based Anxiety Prevention Program : Participants in the prevention program will have weekly sessions with a therapist and will learn skills to help reduce anxiety for 8 weeks. | Evaluation only : Participants will undergo evaluations without active intervention for 8 weeks but received an informational packet on anxiety disorders. |
Measure Participants | 20 | 20 |
Number [participants] |
20
100%
|
20
100%
|
Title | Child Anxiety Diagnoses |
---|---|
Description | The cumulative number of children who developed an anxiety disorder at each assessment point during the study. Using the intent to treat sample, a total of 6 children in the non-intervention group developed an anxiety disorder by the 12-month assessment. No children in the CAPS group developed an anxiety disorder. |
Time Frame | 12 months |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | 1 Family-based Prevention Program | 2 Evaluation Only |
---|---|---|
Arm/Group Description | Family-Based Anxiety Prevention Program : Participants in the prevention program will have weekly sessions with a therapist and will learn skills to help reduce anxiety for 8 weeks. | Evaluation only : Participants will undergo evaluations without active treatment for 8 weeks. |
Measure Participants | 20 | 20 |
Number [participants] |
0
0%
|
6
30%
|
Adverse Events
Time Frame | ||||
---|---|---|---|---|
Adverse Event Reporting Description | ||||
Arm/Group Title | 1 Family-based Prevention Program | 2 Evaluation Only | ||
Arm/Group Description | Family-Based Anxiety Prevention Program : Participants in the prevention program will have weekly sessions with a therapist and will learn skills to help reduce anxiety for 8 weeks. | Evaluation only : Participants will undergo evaluations without active treatment for 8 weeks. | ||
All Cause Mortality |
||||
1 Family-based Prevention Program | 2 Evaluation Only | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | / (NaN) | / (NaN) | ||
Serious Adverse Events |
||||
1 Family-based Prevention Program | 2 Evaluation Only | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/20 (0%) | 0/20 (0%) | ||
Other (Not Including Serious) Adverse Events |
||||
1 Family-based Prevention Program | 2 Evaluation Only | |||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 0/20 (0%) | 0/20 (0%) |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Golda Ginsburg, PhD,Professor |
---|---|
Organization | The Johns Hopkins University School of Medicine |
Phone | 410-955-1544 |
gginnsbu@jhmi.edu |
- K23MH063427
- K23MH063427